Search Results - "Ricaurte, G.A"

Refine Results
  1. 1

    Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum by Ricaurte, G A, Langston, J W, DeLanney, L E, Irwin, I, Brooks, J D

    Published in Neuroscience letters (06-09-1985)
    “…1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a recently described neurotoxin, produces a marked dopamine (DA) depletion in the mouse striatum. In this…”
    Get more information
    Journal Article
  2. 2

    Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) by Ricaurte, G.A, McCann, U.D, Szabo, Z, Scheffel, U

    Published in Toxicology letters (15-03-2000)
    “…The recreational drug, (±)3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), is a potent serotonin (5-HT) neurotoxin in animals. Whether humans who use MDMA…”
    Get full text
    Journal Article
  3. 3

    Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine by Ricaurte, G A, Fuller, R W, Perry, K W, Seiden, L S, Schuster, C R

    Published in Neuropharmacology (01-10-1983)
    “…Repeated administration of large doses of d-methamphetamine produce long-lasting depletion of brain dopamine (DA) and serotonin (5-HT), as well as persistent…”
    Get more information
    Journal Article
  4. 4

    Use of MDMA and other illicit drugs by young adult males in northern Spain. A five-year study by Bobes, J, Sáiz, P A, González, M P, Bascarán, M T, Bousoño, M, Ricaurte, G A, McCann, U D

    Published in European addiction research (01-06-2002)
    “…To measure the prevalence of 3,4-methylenedioxymethamphetamine (MDMA) and other drug use in young males entering compulsory military service in Asturias…”
    Get more information
    Journal Article
  5. 5

    Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration by Ricaurte, G A, DeLanney, L E, Irwin, I, Langston, J W

    Published in Brain research (12-04-1988)
    “…This study compared the toxic effects of oral versus subcutaneous and single versus multiple doses of 3,4-methylenedioxymethamphetamine (MDMA) on central…”
    Get more information
    Journal Article
  6. 6

    Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine by Wilson, M A, Ricaurte, G A, Molliver, M E

    Published in Neuroscience (1989)
    “…Immunohistochemical methods were used to analyse the distribution and morphology of serotonergic axons in normal macaque monkeys and in monkeys given…”
    Get more information
    Journal Article
  7. 7

    Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra by Ricaurte, G A, Irwin, I, Forno, L S, DeLanney, L E, Langston, E, Langston, J W

    Published in Brain research (10-02-1987)
    “…This study assessed the influence of aging on substantia nigra degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Extensive neuronal…”
    Get more information
    Journal Article
  8. 8

    Dexfenfluramine neurotoxicity in brains of non-human primates by Ricaurte, G A, Molliver, M E, Martello, M B, Katz, J L, Wilson, M A, Martello, A L

    Published in The Lancet (British edition) (14-12-1991)
    “…Dexfenfluramine, a drug prescribed for appetite suppression, was evaluated in non-human primates for its potential to produce toxic effects on brain serotonin…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain by Ricaurte, G A, Guillery, R W, Seiden, L S, Schuster, C R, Moore, R Y

    Published in Brain research (04-03-1982)
    “…Numerous recent studies indicate that when amphetamines are administered continuously or in high doses, they exert long-lasting toxic effects on dopamine (DA)…”
    Get more information
    Journal Article
  11. 11

    Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors by Scheffel, U, Lever, J R, Stathis, M, Ricaurte, G A

    Published in Neuropharmacology (01-09-1992)
    “…The present study examined short- and long-term effects of MDMA (3,4-methylene-dioxymethamphetamine) on serotonin (5-HT2 and 5-HT1c) receptors in the brain of…”
    Get more information
    Journal Article
  12. 12

    5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates by Ricaurte, G A, DeLanney, L E, Wiener, S G, Irwin, I, Langston, J W

    Published in Brain research (06-12-1988)
    “…This study examined whether 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF) could be used to detect serotonergic damage induced by…”
    Get more information
    Journal Article
  13. 13

    Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers by Ricaurte, G A, Seiden, L S, Schuster, C R

    Published in Brain research (01-01-1984)
    “…Methamphetamine and amphetamine were continuously administered to rats for 3 days by means of subcutaneously implanted osmotic minipumps. The total daily dose…”
    Get more information
    Journal Article
  14. 14

    Older dopaminergic neurons do not recover from the effects of MPTP by Ricaurte, G A, DeLanney, L E, Irwin, I, Langston, J W

    Published in Neuropharmacology (01-01-1987)
    “…Recent studies have shown that dopaminergic neurons in young mature mice recover fully from toxic injury induced by MPTP. The aim of the present study was to…”
    Get more information
    Journal Article
  15. 15

    Orally administered MDMA causes a long-term depletion of serotonin in rat brain by Finnegan, K T, Ricaurte, G A, Ritchie, L D, Irwin, I, Peroutka, S J, Langston, J W

    Published in Brain research (26-04-1988)
    “…Recent studies suggest that 3,4-methylenedioxymethylamphetamine (MDMA), when administered subcutaneously, is toxic to central serotonergic neurons in rats…”
    Get more information
    Journal Article
  16. 16

    3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain by Ricaurte, G A, Finnegan, K F, Nichols, D E, DeLanney, L E, Irwin, I, Langston, J W

    Published in European journal of pharmacology (04-06-1987)
    “…The present study was carried out to asses possible toxic effects of 3,4-methylenedioxyethylamphetamine (MDE) on serotonergic, dopaminergic or noradrenergic…”
    Get more information
    Journal Article
  17. 17

    Neurochemical similarities between d,l-cathinone and d-amphetamine by Wagner, G C, Preston, K, Ricaurte, G A, Schuster, C R, Seiden, L S

    Published in Drug and alcohol dependence (01-08-1982)
    “…Cathinone, the principal alkaloid of Khat, was compared to the psychomotor stimulant d-amphetamine on a number of neurochemical measures. Like d-amphetamine,…”
    Get more information
    Journal Article
  18. 18

    Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamine by Ricaurte, G A, DeLanney, L E, Irwin, I, Witkin, J M, Katz, J L, Langston, J W

    Published in Brain research (26-06-1989)
    “…The purpose of this study was to evaluate the neurotoxic potential of N,N-dimethylamphetamine (N,N-DMA), a controlled substance analog that has recently…”
    Get more information
    Journal Article
  19. 19

    Nerve terminal degeneration after a single injection of D-amphetamine in iprindole-treated rats: relation to selective long-lasting dopamine depletion by Ricaurte, G A, Guillery, R W, Seiden, L S, Schuster, C R

    Published in Brain research (23-01-1984)
    “…A single injection of D-amphetamine has recently been shown to produce long-lasting dopamine (DA) deficits in rats pretreated with iprindole, an agent which…”
    Get more information
    Journal Article
  20. 20

    The dopamine-depleting effect of 6-hydroxydopamine does not increase with aging by Ricaurte, G A, DeLanney, L E, Finnegan, K T, Irwin, I, Langston, J W

    Published in Brain research (12-01-1988)
    “…The dopamine-depleting effects of intracerebroventricularly administered 6-hydroxydopamine (6-OHDA) were studied in young mature (6-8 weeks), older (8-12…”
    Get more information
    Journal Article